1. Home
  2. MRK
  3. MRK News

Latest Merck & Company Inc. (new) (MRK) News on July 26, 2024

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma
MRK

Business Wire

13 hours ago

Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as First-Line Treatment for Patients With Unresectable or Metastatic Urothelial Carcinoma

MSD reports positive topline data from Phase IIb/III RSV trial in infants
MRK

Clinical Trials Arena

3 days ago

MSD reports positive topline data from Phase IIb/III RSV trial in infants

Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants
MRK

Benzinga

3 days ago

Merck Competes With Sanofi/AstraZeneca As Its RSV Treatment Drug Meets Primary Goal In Late-Stage Study In Infants

Merck Announces Fourth-Quarter 2024 Dividend
MRK

Business Wire

3 days ago

Merck Announces Fourth-Quarter 2024 Dividend

Should You Buy, Sell or Hold Merck (MRK) Ahead of Q2 Earnings?
MRK

Zacks

3 days ago

Should You Buy, Sell or Hold Merck (MRK) Ahead of Q2 Earnings?

Billionaires Are Loading Up on This Surging Dow Stock. Should You?
MRK

Motley Fool

3 days ago

Billionaires Are Loading Up on This Surging Dow Stock. Should You?

Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 78% of the company
MRK

Simply Wall St.

3 days ago

Merck & Co., Inc. (NYSE:MRK) is largely controlled by institutional shareholders who own 78% of the company

Merck claims late-stage study success for RSV antibody
MRK

BioPharma Dive

4 days ago

Merck claims late-stage study success for RSV antibody

Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants
MRK

Business Wire

4 days ago

Merck Announces Topline Results from Phase 2b/3 Trial of Clesrovimab (MK-1654), an Investigational Respiratory Syncytial Virus Preventative Monoclonal Antibody for Infants

Nanotechnology in medicine: Who are the leading public companies?
MRK

Medical Device Network

4 days ago

Nanotechnology in medicine: Who are the leading public companies?

MRK

Argus Research

7 days ago

The Argus Min Vol Model Portfolio

MRK

Argus Research

7 days ago

The Argus Min Vol Model Portfolio

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
MRK

Zacks

8 days ago

Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It

Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness
MRK

Simply Wall St.

8 days ago

Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness

3 High Yield Healthcare Giants With Consistent Dividend Growth: Johnson & Johnson, Merck, And Quest Diagnostics
MRK

Benzinga

8 days ago

3 High Yield Healthcare Giants With Consistent Dividend Growth: Johnson & Johnson, Merck, And Quest Diagnostics

Here for Good: Merck's Steadfast Commitment to Health Equity
MRK

ACCESSWIRE

10 days ago

Here for Good: Merck's Steadfast Commitment to Health Equity

Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024
MRK

Business Wire

11 days ago

Merck to Share New Research and Host Community-Focused Symposia at AIDS 2024

The Zacks Analyst Blog Highlights Exxon Mobil, Merck & Co, Qualcomm and Armanino Foods of Distinction
MRK

Zacks

12 days ago

The Zacks Analyst Blog Highlights Exxon Mobil, Merck & Co, Qualcomm and Armanino Foods of Distinction

Goldman's year of the stock picker, bank earnings reaction : Market Domination
MRK

Yahoo Finance Video

14 days ago

Goldman's year of the stock picker, bank earnings reaction : Market Domination

Healthcare sector at an 'inflection point': Strategist
MRK

Yahoo Finance Video

14 days ago

Healthcare sector at an 'inflection point': Strategist

Top Research Reports for Exxon Mobil, Merck & Qualcomm
MRK

Zacks

14 days ago

Top Research Reports for Exxon Mobil, Merck & Qualcomm

MSD closes $1.3bn EyeBio acquisition, plans pivotal trial for lead asset
MRK

Pharmaceutical Technology

14 days ago

MSD closes $1.3bn EyeBio acquisition, plans pivotal trial for lead asset

Investors in Merck (NYSE:MRK) have seen notable returns of 81% over the past three years
MRK

Simply Wall St.

14 days ago

Investors in Merck (NYSE:MRK) have seen notable returns of 81% over the past three years

Merck Completes Acquisition of EyeBio
MRK

Business Wire

15 days ago

Merck Completes Acquisition of EyeBio

Prelude and MSD partner to trial PRT3789 and Keytruda combination
MRK

Clinical Trials Arena

17 days ago

Prelude and MSD partner to trial PRT3789 and Keytruda combination

Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Dividend Stock to Buy Right Now?
MRK

Insider Monkey

17 days ago

Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Dividend Stock to Buy Right Now?

Merck Animal Health Completes Acquisition of Elanco’s Aqua Business
MRK

Business Wire

17 days ago

Merck Animal Health Completes Acquisition of Elanco’s Aqua Business

Elanco Completes Sale of Aqua Business
MRK

PR Newswire

17 days ago

Elanco Completes Sale of Aqua Business

Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients
MRK

Benzinga

21 days ago

Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer Patients

Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly
MRK

Simply Wall St.

23 days ago

Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
MRK

Benzinga

24 days ago

mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment

N-Power Medicine partners with MSD to expand access to oncology clinical trials
MRK

Clinical Trials Arena

25 days ago

N-Power Medicine partners with MSD to expand access to oncology clinical trials

What's Going On With Merck Stock On Monday?
MRK

Benzinga

25 days ago

What's Going On With Merck Stock On Monday?

Orion to hand over exclusive rights to MSD for prostate cancer therapy
MRK

Pharmaceutical Technology

25 days ago

Orion to hand over exclusive rights to MSD for prostate cancer therapy

Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer
MRK

Business Wire

25 days ago

Merck and Orion Announce Mutual Exercise of Option Providing Merck Global Exclusive Rights to Opevesostat, an Investigational CYP11A1 Inhibitor, for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30
MRK

Business Wire

a month ago

Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30

10 clinical trials to watch in the second half of 2024
MRK

BioPharma Dive

a month ago

10 clinical trials to watch in the second half of 2024

How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
MRK

Benzinga

a month ago

How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?

How Medicare drug price negotiations could hit pharma stocks
MRK

Yahoo Finance Video

a month ago

How Medicare drug price negotiations could hit pharma stocks

What's Going On With Merck Stock On Friday?
MRK

Benzinga

a month ago

What's Going On With Merck Stock On Friday?

Merck’s pneumococcal vaccine gets CDC panel backing
MRK

BioPharma Dive

a month ago

Merck’s pneumococcal vaccine gets CDC panel backing

Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
MRK

Zacks

a month ago

Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)
MRK

Business Wire

a month ago

Merck Receives Positive EU CHMP Opinion for WINREVAIR™ (sotatercept) in Pulmonary Arterial Hypertension (PAH)

CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults
MRK

Business Wire

a month ago

CDC’S ACIP Unanimously Recommends Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Appropriate Adults

Dow Jones Powerhouse Merck Dives On Surprise FDA Rejection
MRK

Investor's Business Daily

a month ago

Dow Jones Powerhouse Merck Dives On Surprise FDA Rejection

FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug
MRK

Benzinga

a month ago

FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug

Merck & Co., Inc.'s (NYSE:MRK) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?
MRK

Simply Wall St.

a month ago

Merck & Co., Inc.'s (NYSE:MRK) Stock Financial Prospects Look Bleak: Should Shareholders Be Prepared For A Share Price Correction?

Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer
MRK

Business Wire

a month ago

Patritumab Deruxtecan BLA Submission Receives Complete Response Letter from FDA Due to Inspection Findings at Third-Party Manufacturer

Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst
MRK

Yahoo Finance Video

a month ago

Novo Nordisk, Eli Lilly still top 2 pharma stocks: Analyst

Capvaxive will enhance protection against pneumococcal disease in older adults
MRK

Clinical Trials Arena

a month ago

Capvaxive will enhance protection against pneumococcal disease in older adults

Pharma M&A: The top high value deals in 2023
MRK

Pharmaceutical Technology

a month ago

Pharma M&A: The top high value deals in 2023

USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza
MRK

Business Wire

a month ago

USDA Approves Merck Animal Health’s NOBIVAC® NXT Canine Flu H3N2 – The First and Only RNA-Particle Technology Vaccine for Canine Influenza

ASCO24: MSD’s ADC shows efficacy in lung and breast tumours
MRK

Pharmaceutical Technology

a month ago

ASCO24: MSD’s ADC shows efficacy in lung and breast tumours

Merck (MRK) Increases Despite Market Slip: Here's What You Need to Know
MRK

Zacks

a month ago

Merck (MRK) Increases Despite Market Slip: Here's What You Need to Know

Is Merck & Co., Inc. (MRK) a Strong Buy Right Now?
MRK

Insider Monkey

a month ago

Is Merck & Co., Inc. (MRK) a Strong Buy Right Now?

With 78% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional owners
MRK

Simply Wall St.

a month ago

With 78% ownership of the shares, Merck & Co., Inc. (NYSE:MRK) is heavily dominated by institutional owners

The 30-stock secret: ‘Don’t fight Papa Dow’
MRK

Yahoo Finance Video

a month ago

The 30-stock secret: ‘Don’t fight Papa Dow’

Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center
MRK

ACCESSWIRE

a month ago

Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center

MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
MRK

Pharmaceutical Technology

a month ago

MSD competes with Pfizer in pneumococcal vaccine market after FDA approval

FDA approves Merck's pneumonia vaccine for adults
MRK

Yahoo Finance Video

a month ago

FDA approves Merck's pneumonia vaccine for adults

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment
MRK

Benzinga

a month ago

Covid-19 Pharma Stars Continue Their Quest To Set New Standards In Cancer Treatment

Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
MRK

Zacks

a month ago

Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval

Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
MRK

BioPharma Dive

a month ago

Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot

Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness
MRK

Simply Wall St.

a month ago

Insiders At Merck Sold US$12m In Stock, Alluding To Potential Weakness

U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults
MRK

Business Wire

a month ago

U.S. FDA Approves CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma
MRK

Business Wire

a month ago

FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Carboplatin and Paclitaxel as Treatment for Adult Patients With Primary Advanced or Recurrent Endometrial Carcinoma

MRK

Argus Research

a month ago

Weekly Stock List

Merck & Co Inc's Dividend Analysis
MRK

GuruFocus.com

a month ago

Merck & Co Inc's Dividend Analysis

MRK

Argus Research

a month ago

Daily Spotlight: Argus Adjusts Sector Ratings

Is Merck & Co. Inc. (NYSE:MRK) The Best Healthcare Stock to Buy in 2024?
MRK

Insider Monkey

a month ago

Is Merck & Co. Inc. (NYSE:MRK) The Best Healthcare Stock to Buy in 2024?

Dividend stocks can help lower your risk. Many are bargains right now.
MRK

MarketWatch

a month ago

Dividend stocks can help lower your risk. Many are bargains right now.

Women in Science? At Merck, Absolutely
MRK

ACCESSWIRE

a month ago

Women in Science? At Merck, Absolutely

MRK

Argus Research

a month ago

May Stock Recovery as Economy Sends Mixed Signals

A Hudson Valley Estate Set on 53 Hilltop Acres Is Listing for $12.25 Million
MRK

The Wall Street Journal

a month ago

A Hudson Valley Estate Set on 53 Hilltop Acres Is Listing for $12.25 Million

Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
MRK

Yahoo Finance

a month ago

Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data

Here’s Why Merck & Co. (MRK) Shares Closed Strongly in Q1
MRK

Insider Monkey

a month ago

Here’s Why Merck & Co. (MRK) Shares Closed Strongly in Q1

MRK

Argus Research

2 months ago

Weekly Stock List

Investors more bullish on Merck (NYSE:MRK) this week as stock climbs 4.1%, despite earnings trending downwards over past three years
MRK

Simply Wall St.

2 months ago

Investors more bullish on Merck (NYSE:MRK) this week as stock climbs 4.1%, despite earnings trending downwards over past three years

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
MRK

Simply Wall St.

2 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
MRK

AFP

2 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
MRK

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
MRK

Simply Wall St.

2 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
MRK

Barrons.com

2 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
MRK

Simply Wall St.

2 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
MRK

Simply Wall St.

2 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?
MRK

Simply Wall St.

2 months ago

Should You Buy OVB Holding AG (ETR:O4B) For Its Upcoming Dividend?

The City With the highest HIV/AIDS Rates in the US
MRK

Insider Monkey

2 months ago

The City With the highest HIV/AIDS Rates in the US

How Merck Scientists Are Driving Next-Generation Cancer Research
MRK

ACCESSWIRE

2 months ago

How Merck Scientists Are Driving Next-Generation Cancer Research

MOBILion Shows Off MOBIE System at ASMS 2024
MRK

Exec Edge

2 months ago

MOBILion Shows Off MOBIE System at ASMS 2024

MRK

Argus Research

2 months ago

Analyst Report: Merck & Co Inc

MRK

Argus Research

2 months ago

Market Digest: MRVL, ADM, APD, MRK, NTAP

Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
MRK

Business Wire

2 months ago

Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Moderna and MSD share encouraging three-year data from trial of melanoma therapy
MRK

Clinical Trials Arena

2 months ago

Moderna and MSD share encouraging three-year data from trial of melanoma therapy

Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma Patients
MRK

Benzinga

2 months ago

Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma Patients

Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection
MRK

ACCESSWIRE

2 months ago

Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection

Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly
MRK

Simply Wall St.

2 months ago

Merck (NYSE:MRK) Seems To Use Debt Quite Sensibly

Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study
MRK

Benzinga

2 months ago

Summit Therapeutics' Lung Cancer Therapy Ivonescimab Shows Improved Progression-Free Survival Versus Merck's Multi-Billion Keytruda In China Study

MRK

Argus Research

2 months ago

The Argus ESG Model Portfolio

MRK

MT Newswires

2 months ago

Merck's Combination Therapy for Cancer Receives Priority Review From FDA

Merck to buy eye drug developer for $1.3B
MRK

BioPharma Dive

2 months ago

Merck to buy eye drug developer for $1.3B

Share on Social Networks: